139 related articles for article (PubMed ID: 18729850)
1. MOZ/TIF2-induced acute myeloid leukaemia in transgenic fish.
Zhuravleva J; Paggetti J; Martin L; Hammann A; Solary E; Bastie JN; Delva L
Br J Haematol; 2008 Nov; 143(3):378-82. PubMed ID: 18729850
[TBL] [Abstract][Full Text] [Related]
2. MOZ-TIF2 repression of nuclear receptor-mediated transcription requires multiple domains in MOZ and in the CID domain of TIF2.
Yin H; Glass J; Blanchard KL
Mol Cancer; 2007 Aug; 6():51. PubMed ID: 17697320
[TBL] [Abstract][Full Text] [Related]
3. MOZ fusion proteins in acute myeloid leukaemia.
Troke PJ; Kindle KB; Collins HM; Heery DM
Biochem Soc Symp; 2006; (73):23-39. PubMed ID: 16626284
[TBL] [Abstract][Full Text] [Related]
4. A further case of acute myeloid leukaemia with inv(8)(p11q13) and MOZ-TIF2 fusion.
Billio A; Steer EJ; Pianezze G; Svaldi M; Casin M; Amato B; Coser P; Cross NC
Haematologica; 2002 May; 87(5):ECR15. PubMed ID: 12010678
[No Abstract] [Full Text] [Related]
5. A further case of acute myelomonocytic leukemia with inv(8) chromosomal rearrangement and MOZ-NCOA2 gene fusion.
Murati A; Adélaïde J; Popovici C; Mozziconacci MJ; Arnoulet C; Lafage-Pochitaloff M; Sainty D; Birnbaum D; Chaffanet M
Int J Mol Med; 2003 Oct; 12(4):423-8. PubMed ID: 12964013
[TBL] [Abstract][Full Text] [Related]
6. ETV6-NCOA2: a novel fusion gene in acute leukemia associated with coexpression of T-lymphoid and myeloid markers and frequent NOTCH1 mutations.
Strehl S; Nebral K; König M; Harbott J; Strobl H; Ratei R; Struski S; Bielorai B; Lessard M; Zimmermann M; Haas OA; Izraeli S
Clin Cancer Res; 2008 Feb; 14(4):977-83. PubMed ID: 18281529
[TBL] [Abstract][Full Text] [Related]
7. Expression of the MOZ-TIF2 oncoprotein in mice represses senescence.
Largeot A; Perez-Campo FM; Marinopoulou E; Lie-a-Ling M; Kouskoff V; Lacaud G
Exp Hematol; 2016 Apr; 44(4):231-7.e4. PubMed ID: 26854485
[TBL] [Abstract][Full Text] [Related]
8. Bromodomain-PHD finger protein 1 is critical for leukemogenesis associated with MOZ-TIF2 fusion.
Shima H; Yamagata K; Aikawa Y; Shino M; Koseki H; Shimada H; Kitabayashi I
Int J Hematol; 2014 Jan; 99(1):21-31. PubMed ID: 24258712
[TBL] [Abstract][Full Text] [Related]
9. Childhood acute myeloid leukemia with hemophagocytosis by the blasts and inv(8)(p11q13) with MOZ-TIF2 fusion transcripts.
Abdelhaleem M; Shago M; Beimnet K; Sayeh E; Bartakke S; Weitzman S
J Pediatr Hematol Oncol; 2007 Sep; 29(9):643-5. PubMed ID: 17805042
[TBL] [Abstract][Full Text] [Related]
10. Ring1A and Ring1B inhibit expression of Glis2 to maintain murine
Shima H; Takamatsu-Ichihara E; Shino M; Yamagata K; Katsumoto T; Aikawa Y; Fujita S; Koseki H; Kitabayashi I
Blood; 2018 Apr; 131(16):1833-1845. PubMed ID: 29371181
[TBL] [Abstract][Full Text] [Related]
11. A role for the transcription intermediary factor 2 in zebrafish myelopoiesis.
Zhuravleva J; Solary E; Chluba J; Bastie JN; Delva L
Exp Hematol; 2008 May; 36(5):559-67. PubMed ID: 18295965
[TBL] [Abstract][Full Text] [Related]
12. Acute mixed lineage leukemia with an inv(8)(p11q13) resulting in fusion of the genes for MOZ and TIF2.
Liang J; Prouty L; Williams BJ; Dayton MA; Blanchard KL
Blood; 1998 Sep; 92(6):2118-22. PubMed ID: 9731070
[TBL] [Abstract][Full Text] [Related]
13. Acute myeloid leukaemia with 8p11 (MYST3) rearrangement: an integrated cytologic, cytogenetic and molecular study by the groupe francophone de cytogénétique hématologique.
Gervais C; Murati A; Helias C; Struski S; Eischen A; Lippert E; Tigaud I; Penther D; Bastard C; Mugneret F; Poppe B; Speleman F; Talmant P; VanDen Akker J; Baranger L; Barin C; Luquet I; Nadal N; Nguyen-Khac F; Maarek O; Herens C; Sainty D; Flandrin G; Birnbaum D; Mozziconacci MJ; Lessard M;
Leukemia; 2008 Aug; 22(8):1567-75. PubMed ID: 18528428
[TBL] [Abstract][Full Text] [Related]
14. MOZ-TIF2-induced acute myeloid leukemia requires the MOZ nucleosome binding motif and TIF2-mediated recruitment of CBP.
Deguchi K; Ayton PM; Carapeti M; Kutok JL; Snyder CS; Williams IR; Cross NC; Glass CK; Cleary ML; Gilliland DG
Cancer Cell; 2003 Mar; 3(3):259-71. PubMed ID: 12676584
[TBL] [Abstract][Full Text] [Related]
15. New types of MYST3-CBP and CBP-MYST3 fusion transcripts in t(8;16)(p11;p13) acute myeloid leukemias.
Murati A; Adélaïde J; Quilichini B; Rémy V; Sainty D; Stoppa AM; Bernard P; Olschwang S; Birnbaum D; Chaffanet M; Mozziconacci MJ
Haematologica; 2007 Feb; 92(2):262-3. PubMed ID: 17296583
[TBL] [Abstract][Full Text] [Related]
16. Rearrangement of the MOZ gene in pediatric therapy-related myelodysplastic syndrome with a novel chromosomal translocation t(2;8)(p23;p11).
Imamura T; Kakazu N; Hibi S; Morimoto A; Fukushima Y; Ijuin I; Hada S; Kitabayashi I; Abe T; Imashuku S
Genes Chromosomes Cancer; 2003 Apr; 36(4):413-9. PubMed ID: 12619166
[TBL] [Abstract][Full Text] [Related]
17. A novel fusion between MOZ and the nuclear receptor coactivator TIF2 in acute myeloid leukemia.
Carapeti M; Aguiar RC; Goldman JM; Cross NC
Blood; 1998 May; 91(9):3127-33. PubMed ID: 9558366
[TBL] [Abstract][Full Text] [Related]
18. Consistent fusion of MOZ and TIF2 in AML with inv(8)(p11q13).
Carapeti M; Aguiar RC; Watmore AE; Goldman JM; Cross NC
Cancer Genet Cytogenet; 1999 Aug; 113(1):70-2. PubMed ID: 10459350
[TBL] [Abstract][Full Text] [Related]
19. MOZ is critical for the development of MOZ/MLL fusion-induced leukemia through regulation of Hoxa9/Meis1 expression.
Katsumoto T; Ogawara Y; Yamagata K; Aikawa Y; Goitsuka R; Nakamura T; Kitabayashi I
Blood Adv; 2022 Oct; 6(19):5527-5537. PubMed ID: 35947126
[TBL] [Abstract][Full Text] [Related]
20. PU.1-mediated upregulation of CSF1R is crucial for leukemia stem cell potential induced by MOZ-TIF2.
Aikawa Y; Katsumoto T; Zhang P; Shima H; Shino M; Terui K; Ito E; Ohno H; Stanley ER; Singh H; Tenen DG; Kitabayashi I
Nat Med; 2010 May; 16(5):580-5, 1p following 585. PubMed ID: 20418886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]